Rezolute, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

RELATED PARTY TRANSACTIONS (Details)

v3.20.2

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ / shares in Units, shares in Millions			1 Months Ended		3 Months Ended
	Sep. 15, 2020	Jul. 23, 2019	Jul. 23, 2019	Jan. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Related Party Transaction [Line Items]
Price per share					$ 14.50
Gross proceeds from issuance				$ 25,000,000
Fair Value Adjustment of Warrants					$ 3,000	$ 2,000
Master Services Agreement ("MSA")
Related Party Transaction [Line Items]
Fair Value Adjustment of Warrants					$ 103,000
Related Party Licensing Agreement
Related Party Transaction [Line Items]
Pharmaceutical License Agreement, Term	20 years
Pharmaceutical License Agreement, Milestone Payment	$ 500,000
Pharmaceutical License Agreement, Transfer Price	70.00%
Milestone payments earned	$ 0
Investor [Member]
Related Party Transaction [Line Items]
Number of shares issued		1.4	1.4
Price per share		$ 14.50	$ 14.50
Gross proceeds from issuance		$ 20,000,000
Ownership interest by related party					65.00%
Investor [Member] \| Master Services Agreement ("MSA")
Related Party Transaction [Line Items]
Investor relation expenses					$ 144,000
General and administrative expenses					$ 247,000

- Definition

The amount of milestone payments to be incurred for the approval of license.

+ References

No definition available.

+ Details

Name:	rzlt_PharmaceuticalLicenseAgreementMilestonePayment
Namespace Prefix:	rzlt_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of milestone payments earned by the entity.

+ References

No definition available.

+ Details

Name:	rzlt_PharmaceuticalLicenseAgreementMilestonePaymentEarned
Namespace Prefix:	rzlt_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Term of pharmaceutical license agreement in years.

+ References

No definition available.

+ Details

Name:	rzlt_PharmaceuticalLicenseAgreementTerm
Namespace Prefix:	rzlt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The percentage of transfer price on sale of products.

+ References

No definition available.

+ Details

Name:	rzlt_PharmaceuticalLicenseAgreementTransferPrice
Namespace Prefix:	rzlt_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The related party interest in net assets of the entity, expressed as a percentage.

+ References

No definition available.

+ Details

Name:	rzlt_RelatedPartnershipOwnershipInterest
Namespace Prefix:	rzlt_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of expense (income) related to adjustment to fair value of warrant liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section 25
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875

+ Details

Name:	us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

+ Details

Name:	us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=rzlt_MasterServicesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=rzlt_RelatedPartyLicensingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: